These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15913493)

  • 21. Carotid baroreflex activation therapy for resistant hypertension.
    Victor RG
    Nat Rev Cardiol; 2015 Aug; 12(8):451-63. PubMed ID: 26149485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrical carotid baroreceptor stimulation.
    Schmidli J; von Allmen RS; Mohaupt MG
    Wien Med Wochenschr; 2014 Dec; 164(23-24):508-14. PubMed ID: 25411011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged activation of the baroreflex abolishes obesity-induced hypertension.
    Lohmeier TE; Dwyer TM; Irwin ED; Rossing MA; Kieval RS
    Hypertension; 2007 Jun; 49(6):1307-14. PubMed ID: 17438305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baroreflex activation therapy in the treatment of resistant hypertension.
    Gordin D; Vikatmaa P; Vikatmaa L; Groop PH; Albäck A; Tikkanen I
    Duodecim; 2016; 132(20):1874-81. PubMed ID: 29190040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension.
    Alnima T; Scheffers I; De Leeuw PW; Winkens B; Jongen-Vancraybex H; Tordoir JH; Schmidli J; Mohaupt MG; Allemann Y; Kroon AA
    J Hypertens; 2012 Aug; 30(8):1665-70. PubMed ID: 22728906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistant hypertension: baroreflex stimulation as a new tool.
    Menne J; Jordan J; Linnenweber-Held S; Haller H
    Nephrol Dial Transplant; 2013 Feb; 28(2):288-95. PubMed ID: 23223217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lowering of blood pressure during chronic suppression of central sympathetic outflow: insight from computer simulations.
    Iliescu R; Lohmeier TE
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):e24-33. PubMed ID: 19769610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of blood pressure reduction by prolonged activation of the baroreflex.
    Iliescu R; Lohmeier TE
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():2040-2. PubMed ID: 19964773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baroreflex activation therapy for patients with drug-resistant hypertension.
    Alnima T; Kroon AA; de Leeuw PW
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):955-62. PubMed ID: 25017430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure.
    Lohmeier TE; Hildebrandt DA; Dwyer TM; Barrett AM; Irwin ED; Rossing MA; Kieval RS
    Hypertension; 2007 Feb; 49(2):373-9. PubMed ID: 17159083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baroreflex activation therapy systems: current status and future prospects.
    Seravalle G; Dell'Oro R; Grassi G
    Expert Rev Med Devices; 2019 Dec; 16(12):1025-1033. PubMed ID: 31774336
    [No Abstract]   [Full Text] [Related]  

  • 32. Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies.
    Alnima T; Goedhart EJ; Seelen R; van der Grinten CP; de Leeuw PW; Kroon AA
    Hypertension; 2015 Jun; 65(6):1217-22. PubMed ID: 25941348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension.
    Tordoir JH; Scheffers I; Schmidli J; Savolainen H; Liebeskind U; Hansky B; Herold U; Irwin E; Kroon AA; de Leeuw P; Peters TK; Kieval R; Cody R
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):414-21. PubMed ID: 17227715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Baroreflex Activation Therapy on Ambulatory Blood Pressure in Patients With Resistant Hypertension.
    Wallbach M; Lehnig LY; Schroer C; Lüders S; Böhning E; Müller GA; Wachter R; Koziolek MJ
    Hypertension; 2016 Apr; 67(4):701-9. PubMed ID: 26902491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baroreflex control of muscle sympathetic nerve activity in mild hypertension.
    Meyrelles SS; Tinucci T; Hollanda HE; Mion D
    Am J Hypertens; 1997 Feb; 10(2):162-7. PubMed ID: 9037323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathophysiological basis of carotid baroreceptor stimulation for the treatment of resistant hypertension.
    Lovic D; Manolis AJ; Lovic B; Stojanov V; Lovic M; Pittaras A; Jakovljevic B
    Curr Vasc Pharmacol; 2014 Jan; 12(1):16-22. PubMed ID: 23905596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapy.
    Lohmeier TE; Iliescu R
    Hypertension; 2011 May; 57(5):880-6. PubMed ID: 21357283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
    Voora R; Hinderliter AL
    Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global- and renal-specific sympathoinhibition in aldosterone hypertension.
    Lohmeier TE; Liu B; Hildebrandt DA; Cates AW; Georgakopoulos D; Irwin ED
    Hypertension; 2015 Jun; 65(6):1223-30. PubMed ID: 25895584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial: interventional management of hypertension and cardiovascular disease: the beginning of a new era?
    Doumas M
    Curr Vasc Pharmacol; 2014 Jan; 12(1):2-3. PubMed ID: 23905600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.